Docstribe Secures Strategic Funding from ABGD Ventures
On Thursday, July 9, 2026, Docstribe, an AI‑powered digital patient‑care journey and precision care coordination platform headquartered in Delhi, announced the closing of a strategic funding round led by ABGD Ventures. The press release states that the investment will accelerate Docstribe’s market expansion across the United States and the United Arab Emirates, markets identified as having strong appetite for healthcare innovation and AI adoption.
Docstribe’s platform activates, engages and monitors patients throughout their care journey, leveraging data‑driven precision medicine to identify high‑risk patients early, improve clinical outcomes, grow revenue and enhance the patient experience across all service lines.
“This investment from ABGD Ventures is a strong validation of what we have been building at Docstribe,” said Akash Manu Srivastava, Co‑Founder of Docstribe. “Our mission has always been to make precision care coordination accessible to healthcare systems that are committed to delivering better outcomes for their patients. With this funding, we are accelerating our entry into the US and UAE markets…”
Sameer Dashputre, General Partner at ABGD Ventures, added that the firm seeks innovative validated health technologies in India to scale in developed markets such as the GCC, US, EU and UK.
The funding will be deployed to (i) accelerate market entry in the US and UAE through dedicated on‑ground teams, (ii) build and deepen partnerships with hospitals, health systems and care networks, and (iii) enhance platform capabilities to meet the specific regulatory and operational needs of each market.
ABGD Ventures describes itself as a health‑tech‑focused venture capital fund that invests in stage‑agnostic Indian health‑tech startups and assists them with clinical validation, regulatory navigation and go‑to‑market execution abroad.
For further information, Docstribe directs readers to its website www.Docstribe.com.